Oct, 2008
Aug, 2008
Jun, 2008
Apr, 2008
News / Therapeutic Area News
CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection
CV Therapeutics, Inc. (Nasdaq: CVTX) and Astellas Pharma US, Inc. today announced that the U.S. Food and Drug...
Read More